Agios Pharmaceuticals | Продажи



Sales Изменить Дата
AbbVie USD 15.1B 642M 2024-12
Agios Pharmaceuticals USD 10.73M 1.77M 2024-12
Alnylam Pharmaceuticals USD 593.17M 92.25M 2024-12
Amgen USD 9.09B 583M 2024-12
Arrowhead Research USD 2.5M 2.5M 2024-12
Astellas Pharma JPY 517.41B 54.91B 2024-12
AstraZeneca USD 14.89B 1.32B 2024-12
Bayer EUR 11.73B 1.76B 2024-12
Biogen USD 2.45B 11.1M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Daiichi Sankyo JPY 484.84B 38.29B 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Exelixis USD 566.76M 27.21M 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
GlaxoSmithKline GBP 8.12B 108M 2024-12
Incyte USD 1.18B 40.83M 2024-12
Ionis Pharmaceuticals USD 226.58M 92.76M 2024-12
Merck USD 15.62B 1.03B 2024-12
Moderna USD 966M 896M 2024-12
Novartis USD 13.15B 330M 2024-12
Novartis USD 13.56B 386M 2024-12
Pfizer USD 17.76B 61M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



Agios Pharmaceuticals Продажи - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2025.